Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-01-13 @ 10:13 PM
Study NCT ID:
NCT00079092
Status:
COMPLETED
Last Update Posted:
2021-09-09
First Post:
2004-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor:
Wake Forest University Health Sciences
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
REBACDR0000354204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |